Hope For Advanced Thymic Cancer Patients: New International Study Targets Rare Cancer
Written on December 10, 2024 - 7:07 am | by admin
The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.
PHA-848125ac is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. It is designed to stop abnormal cell division and duplication, a common feature of cancer.
“From the initial trial in patients with advanced cancers, this drug is well tolerated. Continue training!
Tags: Cancer, Thymic Cancer